Jun Xue
Overview
Explore the profile of Jun Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
285
Citations
2096
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong S, Zhang R, Xue J, Suo Y, Wei X
Neurophotonics
. 2025 Feb;
12(1):015010.
PMID: 39968373
Significance: Alzheimer's disease (AD) is a brain disorder characterized by its multifactorial nature and complex pathogenesis, highlighting the necessity for multimodal and individualized interventions. Among emerging therapies, near-infrared (NIR) light...
2.
Multi-resource constrained elective surgical scheduling with Nash equilibrium toward smart hospitals
Xue J, Li Z, Zhang S
Sci Rep
. 2025 Jan;
15(1):3946.
PMID: 39890977
This paper focuses on the elective surgical scheduling problem with multi-resource constraints, including material resources, such as operating rooms (ORs) and non-operating room (NOR) beds, and human resources (i.e., surgeons,...
3.
Gao L, Liu J, Zhang R, Chen X, Wang M, Dong Y, et al.
Biochem Pharmacol
. 2025 Jan;
233:116783.
PMID: 39880315
Colorectal cancer (CRC), one of the diseases posing a threat to global health, according to the latest data, is the third most common cancer globally and the second leading cause...
4.
Xue J, Huang Q, Yu F, Mao Y
Pacing Clin Electrophysiol
. 2025 Jan;
48(2):180-191.
PMID: 39757426
Purpose: To optimize the effectiveness and safety of pulmonary vein isolation, pulsed-field ablation (PFA) and high-power short-duration ablation (HPSD) have recently been incorporated into clinical practice. The objective of this...
5.
Cheng M, Jin M, Yang S, Zhao L, Yu D, Lin Z, et al.
J Immunother Cancer
. 2025 Jan;
13(1.
PMID: 39755582
Background: Immune checkpoint inhibitors (ICIs) in combination with antiangiogenic drugs have shown promising outcomes in the third-line and subsequent treatments of patients with microsatellite stable metastatic colorectal cancer (MSS-mCRC). Radiotherapy...
6.
Liang X, Zhang C, Xue J, Zheng Y
BMC Neurol
. 2024 Dec;
24(1):475.
PMID: 39643864
Introduction: Whether double filtration plasmapheresis (DFPP) is effective in the patients who do not response to the initial immunotherapy is uncertain. This retrospective study aimed to evaluate the efficacy and...
7.
Wang G, Zhang X, Liang B, Lei J, Xue J
World J Psychiatry
. 2024 Nov;
14(11):1728-1734.
PMID: 39564175
Background: Diagnosing and treating abdominal infection in children remains a challenge. Nucleic acid detection, as a rapid and accurate diagnosis tool, has great significance in this field. Aim: To investigate...
8.
Xue J, Wu D, Bao Y, Wu Y, Zhang X, Chen L
CNS Neurosci Ther
. 2024 Nov;
30(11):e70117.
PMID: 39563017
Aims: Tumorigenicity is a significant concern in stem cell-based therapies. However, traditional tumorigenicity tests using animal models often produce inaccurate results. Consequently, a more sensitive method for assessing tumorigenicity is...
9.
Li M, Li Z, Wu X, Yubo Pan , Wang L, Xue J, et al.
BMC Cancer
. 2024 Nov;
24(1):1413.
PMID: 39548458
Objective: To investigate the specificity of Target of Myb1-Like1 (Tom1L1) expression in colorectal adenocarcinoma tissues and analyze the predictive value of Tom1L1 in the efficacy of neoadjuvant chemotherapy for patients...
10.
Liu J, He H, Wang Y, Du J, Liang K, Xue J, et al.
Elife
. 2024 Nov;
13.
PMID: 39540824
Background: Post-stroke epilepsy (PSE) is a critical complication that worsens both prognosis and quality of life in patients with ischemic stroke. An interpretable machine learning model was developed to predict...